glp 1 and gastroparesis New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events GLP-1 Manufacturers Argue Gastroparesis Lawsuits

Louis, MO) for protease inhibition, according to established protocols 46

GLP-1 medications like Ozempic and Wegovy are changing how people approach weight management

PEG modification increased the stability of protein and peptide drugs, increased the solubility, reduced the immunogenicity, prolonged the residence time in blood, reduced the protease degradation, and reduced the frequency of drug use

Iron deficiency anemia is the most common type of anemia worldwide, affecting over 1.2 billion people globally

Noninvasive monitoring of liver fat during treatment with GLP-1 analogues and SGLT-2 inhibitors in a real-world setting